News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
Pharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Pharmacists MonthEducated PatientInformation for the PharmacistInteractive ToolsPartnersPharmacy Times Oncology Pulse Point: Pharmacist InsightsSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

...PHARMACISTS WIN COMPOUNDING VICTORY

By
October 1st 2006

"One Strong Voice"

ByFred M. Eckel, RPh, M.S.,Pharmacy Times Editor-in-Chief
October 1st 2006

A Pharmacist's Guide to OTCTherapy: Blood Glucose Monitors

ByYvette C. Terrie, BSPharm, RPh
October 1st 2006

Plan B Nonprescription Use: Implications for the Pharmacist

ByJennifer A. Fass, PharmD,Matthew J. Seamon, PharmD, JD Candidate,Erica Seamon, PharmD
October 1st 2006

NJ PHARMACISTS HIT WITH NEW Rx PRICE POSTING LAW

By
October 1st 2006

MENTAL HEALTH ANGUISH STILL HIGH AFTER KATRINA

By
October 1st 2006

MEDICARE CUTS PAYMENTS FOR PHARMACY-MADE ASTHMA DRUGS

By
October 1st 2006

ON-LINE COMMUNICATION NETWORK WILL EXPAND

By
October 1st 2006

ADHD DRUGS HAVE NEW WARNINGS

By
October 1st 2006

CARDINAL HEALTH SUPPORTS COMMUNITY PHARMACY

By
October 1st 2006

WEB SITE TARGETS PHARMACY DIRECTORS

By
October 1st 2006

PHARMACISTS TO PLAY KEY ROLE AS PLAN B GOES OTC

By
October 1st 2006

NORWALK WILL HEAD CMS

By
October 1st 2006

PART D PAYMENT SLOWDOWNS PUSH PHARMACIES TO THE BRINK

By
October 1st 2006

STAR CENTER AIMS TO IMPROVE HOSPITAL PHARMACY PRACTICES

By
October 1st 2006

IS THE PHARMACIST-PATIENT RELATIONSHIP FAILING?

By
October 1st 2006

PART D MISTAKES WILL NOT STOP BENEFITS; CMS STOPS MAILINGS

By
October 1st 2006
  • Prev
  • 1
  • 2
  • 3
  • Prev
Advertisement
Advertisement

Trending on Pharmacy Times

1

Fall 2025 Quiz: Test Your Pharmacy Knowledge!

2

Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health

3

FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms

4

Menopause Care Varies by Provider, Highlighting Need for Standardized Education

5

New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us